CalciMedica (CALC) Non-Current Assets (2019 - 2026)
CalciMedica's (CALC) quarterly Non-Current Assets came in at $54000.0 in Q1 2026, down 58.14% YoY from $129000.0 in Q1 2025, and down 11.48% on a QoQ basis from $61000.0 in Q4 2025.
CalciMedica (CALC) Non-Current Assets (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Non-Current Assets data on file, last reported at $54000.0 in Q1 2026.
- Quarterly Non-Current Assets fell 58.14% year-over-year to $54000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $291000.0 (down 79.12% YoY) and the FY2025 annual result came in at $61000.0, down 52.71% from the prior year.
- Non-Current Assets declined to $54000.0 in Q1 2026, from $61000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $2.4 million in Q1 2022 to a low of $54000.0 in Q1 2026.
- A 5-year average of $606235.3 and a median of $290000.0 in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets slumped 92.77% — and 2024, when it soared 209.94%.
- Tracing CALC's Non-Current Assets over 5 years: stood at $1.6 million in 2022, then tumbled by 64.18% to $580000.0 in 2023, then slumped by 77.76% to $129000.0 in 2024, then slumped by 52.71% to $61000.0 in 2025, then fell by 11.48% to $54000.0 in 2026.
- The last three Non-Current Assets figures came in at $54000.0 (Q1 2026), $61000.0 (Q4 2025), and $60000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40,000.00 |
| Mar 31, 2026 | 54,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Dec 31, 2024 | 129,000.00 |
| Sep 30, 2024 | 526,000.00 |
| Jun 30, 2024 | 610,000.00 |
| Mar 31, 2024 | 530,000.00 |
| Dec 31, 2023 | 580,000.00 |
| Sep 30, 2023 | 572,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 171,000.00 |
| Dec 31, 2022 | 1.62 Mn |
| Sep 30, 2022 | 290,000.00 |
| Jun 30, 2022 | 2.30 Mn |
| Mar 31, 2022 | 2.36 Mn |
| Dec 31, 2021 | 2.01 Mn |
| Sep 30, 2021 | 2.14 Mn |